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Exposure to ambient air pollution is strongly associated with increased cardiovascular 
morbidity and mortality. Little is known about the influence of air pollutants on cardiac 
structure and function. We aim to investigate the relationship between chronic past exposure 
to traffic-related pollutants and the cardiac chamber volume, ejection fraction and left 
ventricular remodelling patterns after accounting for potential confounders. 
 
Methods  
Exposure to ambient air pollutants including particulate matter and nitrogen dioxide was 
estimated from the Land Use Regression models for years between 2005 and 2010. Cardiac 
parameters were measured from cardiovascular magnetic resonance imaging studies of 3,920 
individuals free from pre-existing cardiovascular disease in the UK Biobank population study. 
The median (interquartile range [IQR]) duration between the year of exposure estimate and the 
imaging visit was 5.2 (0.6) years. We fitted multivariable linear regression models to 
investigate the relationship between cardiac parameters and traffic-related pollutants after 
adjusting for various confounders.  
 
Results 
The studied cohort was 62±7 years old and 46% were men. In fully-adjusted models, fine 
particulate matter (PM2.5) concentration was significantly associated with larger left ventricular 
end-diastolic volume and end-systolic volume (effect size = 0.82%, 95% confidence interval 
[CI] = 0.09 to 1.55%, p = 0.027 and effect size = 1.28%, 95% CI = 0.15 to 2.43%, p = 0.027, 
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respectively, per IQR increment in PM2.5) and right ventricular end-diastolic volume (effect 
size = 0.85%, 95% CI = 0.12 to 1.58%, p = 0.023, per IQR increment in PM2.5). Likewise, 
higher nitrogen dioxide (NO2) concentration was associated with larger biventricular volume. 
Distance from the major roads was the only metric associated with lower left ventricular mass 
(effect size = -0.74%, 95% CI = -1.3% to -0.18%, p = 0.01, per IQR increment). Neither left 
and right atrial phenotypes nor left ventricular geometric remodelling patterns were influenced 
by the ambient pollutants.  
 
Conclusions 
In a large asymptomatic population with no prevalent cardiovascular disease, higher past 
exposure to PM2.5 and NO2 was associated with cardiac ventricular dilatation, a marker of 
adverse remodelling which often precedes heart failure development.  
 










What is New? 
• Although ambient air pollutants are known to be associated with increased 
cardiovascular morbidity and mortality, limited information is available on the link 
between air pollutants and cardiac structure and function.   
• In this cross-sectional analysis of a large population free from pre-existing 
cardiovascular disease, higher past exposure to fine particulate matter (PM2.5) and 
nitrogen dioxide (NO2) were associated with larger cardiac biventricular volumes, 
which is a well-recognised pathophysiological adaptation, heralding heart failure 
development.  
• Proximity to major roads, a surrogate for chronic air pollution exposure, was 
additionally associated with higher left ventricular mass which is known to portend 
adverse outcomes.  
What Are the Clinical Implications? 
• The association between ambient air pollution and adverse cardiac phenotypic 
changes in individuals without prevalent cardiovascular disease suggests that air 
pollution should be recognised as a major modifiable risk factor which needs to be 
targeted via public health measures. 
• These cardiac morphological alterations are apparent despite relatively low exposure 
levels meeting the current air quality standards, making a strong case to double efforts 






Deleterious effect of air pollutants on cardiovascular health is well established. Several 
studies have demonstrated strong associations between exposure to air pollution and 
increased risks of coronary artery disease, heart failure, stroke, cardiovascular mortality and 
all-cause mortality 1. Traffic-related environmental pollution consists of a complex mixture 
of gaseous and particulate components, alongside auxiliary elements such as noise and 
psychological stress. Amongst all air pollutants, particulate matter (PM) pollution – 
specifically fine particulates with an aerodynamic diameter less than 2.5µm (PM2.5) – has 
repeatedly been associated with cardiovascular morbidity and mortality. Inhalation of PM2.5 
can initiate and sustain physiological and biochemical changes through elevation of 
pulmonary and systemic inflammatory and oxidative stress, autonomic imbalance, 
endothelial dysfunction, hypertension, atherosclerosis, and thrombosis, which are all key 
substrates for adverse cardiac remodelling leading to detrimental outcomes 2.  
 
Cardiac morpho-functional parameters are prognostically important biomarkers in health and 
disease. Left ventricular (LV) mass, for example, is a well-recognised predictor of 
cardiovascular morbidity and mortality even in individuals without established cardiovascular 
disease (CVD) 3. LV geometric patterns and the morpho-functional indices of other cardiac 
chambers also carry prognostic information in the setting of CVD 4–11. Although the 
associations between ambient air pollutants and increased incidence of myocardial infarction 
and heart failure have been established 12,13, there is a paucity of information in the current 
literature about the influence of air pollution on cardiac structure and function. Determining 
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the impact of individual air pollutant on cardiac phenotypes is challenging for several reasons 
due to socioeconomic confounders, relatively small effect sizes and the variability of 
exposure and outcome measurement techniques.  
The UK Biobank is a large-scale prospective cohort study of half a million people, aged 
between 40-69 years. In addition to a rich repository of information on demographics, risk 
factors and environmental exposure data, a sub-group of UK Biobank participants undergo 
deep phenotyping with cardiovascular magnetic resonance (CMR), which is the reference 
imaging modality for quantification of the cardiac structural phenotypes 14. In this study, we 
aim to explore the association between chronic past exposure to traffic-related ambient air 
pollution and the cardiac imaging parameters after accounting for various potential 
confounders in the UK Biobank cohort. We hypothesised that annual average air pollutants 
and other traffic-related factors quantified approximately 5 years prior to cardiac imaging 
have a detectable adverse association with cardiac imaging phenotypes in individuals free 






The data, analytic methods, and study materials will be returned to the UK Biobank. The UK 
Biobank will make these data available to all bona fide researchers for all types of health-
related research that is in the public interest, without preferential or exclusive access for any 
person. All researchers will be subject to the same application process and approval criteria 






The UK Biobank is a large population-based prospective cohort study which has collected a 
wealth of information on health and lifestyle data, physical measurements, biological 
samples, and cardiac phenotypes derived from CMR. This ambitious project aims to provide 
resources to disentangle the genetic and environmental determinants of complex diseases 
affecting middle and old age. The study protocol has been described in detail previously 15. In 
brief, approximately 9.2 million UK residents aged between 40-69 years, who were registered 
with the UK National Health Service and living up to twenty-five miles from one of the 22 
study assessment centres, were invited to join the study. Amongst those who responded the 
invite, more than 500,000 people were enrolled in 2006 to 2010. The sample size of 500,000 
was calculated a priori for reliable detection of the effects of different exposures on a wide 
variety of conditions in nested case-control studies. Although the UK Biobank cohort is not 
designed to be representative of the UK general population (due to ‘healthy volunteer’ 
selection bias), it is well-suited to study exposure-disease relationships due to its large size 
and heterogeneity of exposure measures 16. The baseline summary characteristics of the 
cohort can be viewed in the data showcase on UK Biobank’s website 
(www.ukbiobank.ac.uk). The CMR imaging sub-study was commenced in 2014 and this 
study included the first 5,065 consecutive participants who returned for imaging 
enhancement in 2014-2015. The study complies with the Declaration of Helsinki and was 
approved by our institutional review body. All participants provided informed written 
consent. The UK Biobank’s scientific protocol and operational procedures were approved by 
the Northwest Research Ethics Committee in the UK.  
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Ambient air pollution, noise and traffic exposure 
 
The annual average concentration of PM2.5, PM10 (PM with an aerodynamic diameter of less 
than 10 µm), PMcoarse (PM with an aerodynamic diameter between 2.5 to 10 µm), PM2.5 
absorbance (a measurement of the blackness of PM2.5 filter – a proxy for elemental or black 
carbon), nitrogen dioxide (NO2) and nitrogen oxides (NOx) were calculated centrally by the 
UK Biobank using a Land Use Regression (LUR) model developed by the European Study of 
Cohorts for Air Pollution Effects (ESCAPE) project 17,18. LUR models calculate the spatial 
variation of annual average air pollutant concentration at participants’ home addresses given 
at the baseline visit, using the predictor variables obtained from Geographic Information 
System (GIS) such as traffic, land use, and topography. Since NO2 and PM10 annual 
concentration data were available for several years (2005, 2006, 2007 and 2010 for NO2 and 
2007 and 2010 for PM10), we averaged the values to get the mean estimate. All other 
particulate matter and nitrogen pollutants had the exposure data for a single year (2010). The 
median leave-one-out cross-validated variance explained by the model was 71% for PM2.5, 
77% for PM10, 68% for PMcoarse, 89% for PM2.5 absorbance, 82% for NO2 and 78% for NOx.  
 
Average exposure to noise for year 2009 was estimated from a model based on common 
noise assessment methods in Europe (CNOSSOS-EU) 19. This technique allows large-scale 
noise mapping for epidemiological studies using data on traffic flow, speed and composition, 
land cover, building heights, road network, air temperature, and wind direction. Noise 
pollution was represented by 24-hour (daily) sound pressure level (A-weighted sound level in 
decibels) averaged over a year as suggested by World Health Organization 20.  
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Traffic intensity on the nearest major road was defined as the total number of motor vehicles 
per 24 hours, averaged over the course of one year. The traffic count and road network data 
were provided by the UK Department for Transport and the Ordnance Survey Meridian 2 
(OSM2) road network (scale 1:50000, 1 metre accuracy) in year 2009. Proximity to traffic 




The detailed CMR protocol and analysis methods have been described previously 21. In brief, 
all CMR studies were acquired with a wide bore 1.5 Tesla scanner (MAGNETOM Aera, 
Syngo Platform VD13A, Siemens Healthcare, Erlangen, Germany) and analyses were 
performed using cvi42 post-processing software (Version 5.1.1, Circle Cardiovascular 
Imaging Inc., Calgary, Canada). LV mass and volumes; right ventricular (RV) volumes; left 
atrial (LA) and right atrial (RA) volumes were manually measured from balanced steady-
state free precession (bSSFP) cine short and long axis images. The following cardiac 
phenotypes were included: LV end-diastolic volume (LVEDV), LV end-systolic volume 
(LVESV), LV ejection fraction (LVEF), LV mass (LVM), RV end-diastolic volume 
(RVEDV), RV end-systolic volume (RVESV), RV ejection fraction (RVEF), LA maximal 
volume, LA ejection fraction (LAEF), RA maximal volume, RA ejection fraction (RAEF), 
and LV geometric remodelling patterns. The LV geometric remodelling patterns were 
classified according to LV mass indexed to body surface area and LV mass to end-diastolic 
volume ratio (LVMVR, CMR-equivalent of relative wall thickness) as previously described 
22. Normal cut-off values for LV mass and LVMVR were obtained from the 95% prediction 
intervals of sex-specific reference ranges 21. Four distinct LV geometric remodelling patterns 
were defined: (i) Normal (normal indexed LV mass and LVMVR), (ii) Concentric 
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remodelling (normal indexed LV mass and increased LVMVR), (iii) Eccentric hypertrophy 
(increased indexed LV mass and normal LVMVR), and (iv) Concentric hypertrophy 




Since air pollution estimates were modelled using participants’ home address given at the 
baseline visit, we restricted the data analysis to those who remained at the same address 
between the baseline and imaging visits. We also excluded individuals with any known 
cardiovascular disease based on the self-reported questionnaires and hospital episode data in 
order to mitigate the potential impact of established cardiac conditions on the imaging 
parameters. All continuous variables were assessed for normality using histograms and 
quantile-quantile plots. Natural logarithmic transformation was performed on non-Gaussian 
dependent variables where possible. Descriptive statistics for continuous variables were 
presented as mean (standard deviation [SD]) or median (interquartile range [IQR]) while 
categorical variables were presented as number (percentage).  
We imputed missing data by multiple imputation by chained equations (MICE) approach to 
create 50 complete datasets 23. We used predictive mean matching for continuous variables, 
logistic regression for binary variables, and polytomous regression for categorical variables. 
All covariates and interaction terms were included in the imputation models. The maximum 
iteration was set at 50 and convergence was confirmed by visual examination of trace plots.  
We constructed separate multiple linear regression models to examine the associations 
between each air pollutant and continuous cardiac CMR variables. For categorical LV 
geometric remodelling patterns, we used multinomial logistic regression to model the effect 
of pollution. In all statistical models, we adjusted for: (i) demographics – age at imaging visit, 
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sex, and ethnicity; (ii) anthropometrics – height, and body mass index (BMI); (iii) 
socioeconomic factors – average household income, employment status, Townsend 
deprivation index, and educational attainment; (iv) cardiac risk factors – systolic blood 
pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), smoking status, regular 
alcohol use, hypertension, diabetes mellitus, and respiratory disease; (v) medications – anti-
hypertensive medication, lipid-lowering medication, and insulin; (vi) physical activity –
seven-day average acceleration from accelerometer. All covariates were chosen a priori for 
their established or presumed influence on the cardiovascular structure and function. The 
measurement protocols and covariate definitions were provided in the “Definitions of 
covariates” section in Supplemental Methods. The beta-coefficients (effect estimates) of log-
transformed variables were anti-logged and expressed as percentage change. The mean 
estimates and standard errors of the beta-coefficients for the imputed datasets were combined 
with Rubin’s rules (see Supplemental Methods) 24. Since we have scaled all pollutants by 
their respective IQR before entering into the regression models, their effect estimates 
represent the change in dependent CMR variable per IQR increment in pollutant.   
 
We conducted the following secondary analyses: (i) an analysis of effect modification by age, 
sex, and smoking status by introducing cross-product terms, (ii) an analysis excluding 
hypertension, diabetes, SBP, DBP, and HR due to their potential mediating effects on the 
relationship between air pollution and cardiac phenotypes, (iii) an analysis of the 
confounding effects of noise and proximity to traffic on the significant associations between 
air pollutants and cardiac measurements, and (iv) an analysis of cases with clinically 
unrecognized myocardial infarction (MI) based on the evaluation of CMR images. Cases with 
possible MI were first selected by identifying thin left ventricular myocardial segments (end-
diastolic wall thickness < 5.5 mm for the basal and mid segments) and possible regional 
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hypokinesis (systolic wall thickening – end-systolic wall thickness minus end-diastolic wall 
thickness – of < 2mm) as recommended by Baer et al. 25,26. These cases were then manually 
evaluated by three analysts with significant experience in reporting clinical CMR studies 
(MK, NA – both EACVI CMR level 3-certified cardiologists – and KF with four years’ 
experience in reporting clinical CMR studies).   
 
Sensitivity analyses were conducted by: (i) restricting the sample to participants with 
complete data, (ii) indexing continuous CMR-derived phenotypes by height2.7 , and (iii) 
restricted cubic spline (RCS) transformation of exposure variables to investigate non-linear 
relationships. The optimal number of knots for RCS-transformed variables was determined 
by the Akaike information criterion. Non-linearity was assessed with the analysis-of-variance 
F statistics and visualized with line plots. The regression model assumptions were checked 
with residuals plots. A p-value of < 0.05 was considered significant. Multiple imputation, 
multinomial regression and restricted cubic spline transformation were performed using 
‘mice’, ‘nnet’ and ‘rms’ packages, respectively 27–29. We used R (version 3.4.3) for all 




Baseline demographics  
 
A total of 5,065 individuals were considered for this study. Of these, we excluded 738 
individuals who had moved home between the baseline and imaging visit. A further 407 
individuals were excluded due to pre-existing CVD – highest prevalent CVD was coronary 
artery disease (n [%] = 198 [4.6%]), resulting in 3,920 individuals included in the final 
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analysis (Figure 1). The baseline characteristics of the final cohort are presented in Table 1. 
The mean age of the cohort was 61.7 years and 45.6% were men. The median (IQR) annual 
average concentration of the two main pollutants, PM2.5 and NO2, were 9.9 (1.32) µg/m3 and 
28.2 (11.4) µg/m3, respectively. The median (IQR) duration between the year of exposure 
estimate and the imaging visit was 5.2 (0.6) years. There was no clinically significant 
difference in characteristics between the whole cohort and complete cases without missing 
data (Supplemental Table 1).  
 
Relationship between particulate matter pollutants and cardiac phenotypes 
 
The associations between particulate matter pollutants and cardiac phenotypes are presented 
in Table 2 and Figure 2. After adjustment for all covariates, PM2.5 concentration was 
significantly associated with larger biventricular volume (effect size for LV EDV = 0.82%, 
95% confidence interval [CI]: 0.09 to1.55%, p = 0.027; effect size for LV ESV = 1.28%, 
95% CI: 0.15 to 2.43%, p = 0.027; effect size for RV EDV = 0.85%, 95% CI: 0.12 to 1.58%, 
p = 0.023, per IQR increment in PM2.5 concentration). Likewise, PM10 had identical 
association patterns with slightly smaller magnitude of effect sizes per IQR increment. 
Neither PM2.5 nor PM10 was associated with other cardiac parameters and LV geometric 
remodelling patterns. PMcoarse and PM2.5 absorbance did not have any association with the 
cardiac phenotypes.   
 
Relationship between oxides of nitrogen and cardiac phenotypes 
 
Table 3 presents the relationships between nitrogen pollutants and cardiac parameters after 
adjustment for all covariates. Higher NO2 concentration was significantly correlated with 
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larger LV EDV and RV EDV (effect size for LV EDV = 0.91%, 95% CI: 0.12 to 1.7%, p = 
0.025; effective size for RV EDV = 0.85%, 95% CI: 0.06 to 1.65%, p = 0.035, per IQR 
increment in NO2 concentration) (Figure 2). However, NOx had no significant association 
with CMR-derived measurements.  
 
Relationship between noise, road traffic factors and cardiac phenotypes 
 
The associations between noise, distance to the nearest major road and traffic intensity and 
CMR-derived phenotypes are detailed in Table 4. Being exposed to higher ambient sound 
level was associated with larger LV ESV (effect size = 0.69%, 95% CI: 0.03 to 1.35%, p = 
0.041, per IQR increment in 24-hour sound level averaged over a year). Interestingly, in 
addition to the significant association with biventricular volume, living further away from 
major roads was also associated with lower LV mass (effect size =   -0.74%, 95% CI: -1.3 to 
-0.18%, p = 0.01, per IQR increment in distance to major roads). There was no significant 
relationship between traffic intensity and any of the cardiac morpho-functional phenotypes.  
 
Effect modification and mediator analyses 
 
We investigated if age, sex, and smoking status modify the significant relationships between 
each pollutant and cardiac phenotypes. Smoking status was the only important effect 
modifier, where being a current smoker significantly enhanced the positive association 
between PM10 concentration and RVEDV (effect size difference = +3.3% for current smoker 
compared to non-smoker, 95% CI: 0.06 to 6.7%, p = 0.046). The regression models which 
were not adjusted for hypertension, diabetes, SBP, DBP and HR produced results with 
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similar magnitude in effect size when compared with the fully-adjusted models 
(Supplemental Tables 2-4).  
 
The wall motion assessment to determine unrecognized MI cases revealed 600 cases with 
possible regional wall motion abnormalities (RWMA) based on cut-off values of LV end-
diastolic wall thickness < 5.5mm and LV systolic wall thickening of < 2mm. After manual 
evaluation, we discovered 43 CMR studies with truly hypokinetic LV segments (10 studies 
with global hypokinesis and 33 studies with regional hypokinesis). The distribution of 
hypokinetic segments in the 33 cases with RWMA are displayed in Supplemental Figure 1. 
We observed that mid to apical inferior and lateral segments were most commonly affected. 
Due to the limited number of cases with probable unrecognised MI based on cine CMR data 
(<1% of the entire cohort), we were not able to assess the relationship between air pollution 
and unrecognised or unreported MI.  
 
We found that the associations between PM2.5 and NO2 concentrations and LV volume were 
not independent of noise or distance to major roads and vice-versa (i.e., the relationships 
between noise/distance to major roads and LV volume were also confounded by PM2.5 and 
NO2). The associations between PM2.5 and NO2 and RV volume were independent of noise 




Sensitivity analyses including only participants with complete data gave no materially 
different results. Equivalently, fitting the models with continuous CMR parameters indexed 
to height2.7 produced similar findings. There was no consistent evidence to support non-linear 
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relationships between air pollutants and cardiac measurements (Supplemental Figure 2). The 
fitted model diagnostic plots showed no evidence of heteroscedasticity or deviation from 




In a cross-sectional investigation of 3,920 individuals free from known cardiovascular 
disease, this study identified the following important findings: (i) higher concentration to 
PM2.5 and NO2 were associated with biventricular enlargement; (ii) the lack of association 
between PMcoarse and cardiac phenotypes suggests that the association between PM and 
cardiac chamber size was predominantly driven by the finer particles; (iii) other 
environmental stressors such as noise pollution and proximity to major roads were also 
correlated with LV dilatation; (iv) amongst all traffic-related factors, only proximity to major 
roads was predictive of higher LV mass; (v) no perceptible difference in traditional LV 
geometric remodelling pattern in relation to differing air pollutant concentration was found.  
 
Accumulating evidence based on meta-analyses indicates an increased risk of heart failure 
hospitalisation associated with higher PM2.5 and NO2 exposure (1.28% increase in risk per 10 
µg/m³ increase in PM2.5 and 1.7% increase in risk per 10 parts per billion increase in NO2) 
13,31. However, the connection between air pollution and cardiac remodelling, which is likely 
to precede the development of heart failure by months to year, had not received an in-depth 
investigation. Previous studies in this arena typically examined a limited number of pollutants 
or cardiac phenotypes 32–34, animal models 35,36 or had relatively small sample sizes 37,38. Our 
study is the largest single epidemiological study to date that investigated the association 
between chronic exposure to several traffic-related pollutants and cardiac structural variations 
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using highly precise and reproducible CMR measurements, which further enhanced the 
statistical power.   
This is the first study to report the association between PM2.5 and NO2 concentration and LV 
dilatation – an ominous sign which often heralds cardiac decompensation – in a population 
free from pre-exiting cardiovascular disease.  
 
Association between ambient pollutants and cardiac parameter – summary of evidence 
 
The findings from this study should be interpreted in the context of the currently available 
evidence in animal and human studies. In a controlled-exposure study with mice, prolonged 
exposure to concentrated PM2.5 (mean exposure chamber concentration of 85.3 µg/m3) led to 
increased LV dimensions, decreased fractional shortening and reduction in contractile reserve 
to dobutamine 36. Similarly, in-utero and early life exposure to concentrated PM2.5 in mice 
appeared to increase LV cavity size and impair LV function with histological evidence of 
cardiac collagen deposition 39,40. A human study which assessed the cross-sectional 
association between residential air pollution and cardiac measurements derived from 
echocardiogram (ECHO) in 671 White Europeans found a reduction in LV longitudinal strain 
and strain rate with higher levels of PM2.5, PM10, NO2 and black carbon 38. Similar to our 
study, no association was found between the ambient pollutants and the LA volume, LV mass 
or LV EF. However, in contrast to our study, they found no correlation between LV 
dimension and the ambient pollutants, which could be explained by the well-recognised 
limitation of two-dimensional (2D) ECHO in measurement of LV dimensions and the study 
being significantly underpowered. The Study on the Influence of Air Pollution on Lung 
(SALIA) cohort with 264 elderly women (mean age of 74.4 years) reported some signals of 
association between larger indexed LA volume and higher PM2.5, NO2 and NOx exposure 41. 
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The lack of association between LA size and pollution concentration in our study could be 
due to much lower level of exposure (mean PM2.5 of 9.86 µg/m3 in our cohort vs 17.4 µg/m3 
in SALIA cohort) and younger age of the participants.  
 
Another ECHO-based study by Weaver et al. in 4,866 African-American individuals 
(Jackson Heart Study (JHS)) did not find any association between the distance to major roads 
and LV EF and LA diameter index, in parallel to our results 42. Intriguingly, they reported a 
small increase in pulmonary artery systolic pressure (PASP) in those living 300-999m from 
major roads (compared to those who lived ≥ 1000m) – a finding which may explain the 
mechanism of RV dilatation in relation to the distance to major roads observed in our study. 
A follow-up study in the same JHS cohort found a 1.2mm larger LV end-systolic diameter in 
participants residing < 150m from a major road in comparison to those living ≥ 1000m), 
although no association was detected between indexed LV mass and proximity to major roads 
43.  
 
Perhaps, the most comparable study to-date was conducted in the Multi-ethnic Study of 
Atherosclerosis (MESA) cohort (sample size of 3,827; age 45-84 years), which also 
underwent CMR imaging 32. Interestingly, they only investigated the impact of PM2.5 and 
proximity to traffic on LV EF and LV mass. In their fully-adjusted models, living within 50m 
of a major road was associated with higher indexed LV mass while PM2.5 did not influence 
LV mass or LV EF – these results are consistent with our findings. Another MESA study by 
Leary and colleagues which explored the relationship between NO2 and NOx exposure and 
RV phenotypes observed a small increase RV mass and RV EDV per IQR increase in NO2 33; 
the latter finding was replicated in our study, however, RV mass was not available in our 
cohort for comparison.   
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All available epidemiologic evidence to-date including our findings suggests that ambient 
particulate and nitrogen pollutants predominantly affect the ventricular chamber size and 
possibly, the long-axis function, while exerting a minimal influence on other cardiac indices 
such as LV radial function or LA size. Residential proximity to major roadways is regarded 
as a surrogate for long-term exposure to traffic-related pollutants and has been known to be 
associated with adverse cardiovascular and pulmonary outcomes 44. Unlike the ambient 
pollutants, it is associated with higher LV mass, a well-recognised cardiovascular 
prognosticator, which could be due to the contributions from unmeasured noxious elements 
(such as sympathetic stimulation from stress and annoyance) and residual confounding from 
latent socioeconomic factors. Given the known links between coronary artery disease and air 
pollution, the effect estimates of the associations between air pollutants and cardiac 
parameters in our study are likely to be conservative due to a priori exclusion of individuals 
with pre-existing CVD. 
 
Biological mechanisms mediating cardiac remodelling 
 
Air pollution exposure is known to be associated with elevation of oxidative stress, immune-
mediated systemic inflammation and hypercoagulation which can induce atherosclerosis, 
myocardial ischaemic damage and associated cardiac remodelling 45–48. Indeed, ventricular 
enlargement in association with PM2.5 and NO2 in our cohort free from known cardiovascular 
disease could be due to adverse remodelling secondary to unrecognized or silent MI. In our 
study, the prevalence of probable MI based on cine CMR data was low (<1% of the entire 
cohort). Although the true prevalence of silent MI is likely to be higher, we were unable to 
ascertain subtle subendocardial infarction in the absence of late gadolinium contrast 
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enhancement images. The population prevalence of unrecognized MI was previously reported 
to be 16.7%  in an Icelandic cohort 49, although the latter imaged a much older population 
(mean age of 76.7 years vs 61.7 years in our study) and had benefited from augmented 
sensitivity and specificity afforded by the aforementioned contrast agent. Another potential 
contributing mechanism is through vasoconstriction and systemic hypertension due to a 
combination of endothelial dysfunction and autonomic imbalance. However, in our study, 
systolic and diastolic components of blood pressure and presence of hypertension do not 
appear to mediate the association between air pollution and cardiac parameters, suggesting 
that oxidative stress is likely to be predominantly responsible for cardiac phenotypic 
alterations which often precede clinical heart failure.  
 
Strength and Limitations 
 
Our study is the first to report the deleterious influence of a wide range of ambient pollutants 
on prognostically important cardiac chamber size in humans free from any pre-existing 
cardiovascular disease. The strengths of this study include a large sample size, highly 
accurate and reproducible measurements by CMR imaging and uniform data collection 
protocols which increase the precision of effect estimates. Our study has a number of 
limitations. First, we used estimated outdoor pollution at participants’ home address which 
does not take into account (i) individual activity pattern such as time spent at home or in 
traffic, (ii) degree of pollutant infiltration into buildings, and (iii) indoor air pollution and 
workplace exposure. Second, biomarkers of oxidative damage such as malondialdehyde 
(MDA), 4-hydroxy-2-nonenal (4-HNE), 4-oxo-2-nonenal (4-ONE), and acrolein, were not 
measured in our cohort which prevented us from validating our findings mechanistically. 
Third, multiple testing correction was not performed for the regression models. However, the 
 22 
inflation of type-I error may be somewhat diminished, although not completely removed, by 
correlation within exposure and outcome variables – approximately 70% of ambient air 
pollutants (exposure) and directly-measured CMR variables (outcome) were at least 
moderately inter-correlated (Pearson correlation coefficient [r] > 0.5) and ~ 30% of both 
exposure and outcome variables were significantly correlated (Pearson r > 0.7). Finally, the 
intrinsic weaknesses of the cross-sectional study design mean that the findings should be 




The current European standard of acceptable annual PM2.5 concentration is less than 25 
µg/m3 while the World Health Organisation (WHO) air quality guidelines stipulate a more 
stringent long-term target of 10 µg/m3 50,51. Although the relatively low average 
concentration level in our study population not only achieves the WHO target but surpasses 
the current European standard by a significant margin, we observed a detectable cardiac 
remodelling effect which usually heralds detrimental outcomes. Although the effect sizes 
found in our analyses are relatively small, they are comparable to the impact of other 
cardiovascular risk factors on cardiac phenotypes (for example, a previous study in the same 
cohort reported a 2% larger LV ESV per SD [18.1 mmHg] increase in SBP vs  a 1.28% larger 




In this large UK-wide middle-aged population, we found a significant association between 
higher annual average PM2.5 and NO2 concentration and larger biventricular volume, which is 
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a hallmark of adverse cardiac remodelling. These cardiac structural alterations in the absence 
of known cardiovascular disease alludes to a silent pathophysiological adaptation which 
should be monitored and targeted for treatment. Our findings add to the growing evidence of 
the damaging effects of ambient pollution even in the setting of relatively low exposure 
levels. Efforts to reduce air pollutant emission should be prioritised accordingly in public 
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Figure titles and legends 
 
Figure 1. Case selection flowchart 
Figure 2. Association between annual average concentrations of PM2.5 and NO2 and cardiac 
parameters 
The figure shows the marginal means (with 95% confidence interval) of cardiac parameters at 
different levels of PM2.5 and NO2 concentrations. Marginal means were estimated from the 
linear regression models adjusted for all covariates. Intervals of pollutant concentrations (x-
axis) were chosen to closely represent the range of pollutant concentration observed in the 
cohort.  
Higher levels of PM2.5 and NO2 were associated with larger LVEDV and RVEDV. No 
significant association was observed between air pollutants and other cardiac parameters.  
LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right atrium; EDV, end-diastolic 














Table 1. Participant characteristics 
 
 Entire cohort 
(N=3,920) 
Demographics  
Age, years 61.7 (7.4) 
Male sex 1787 (45.6) 
Caucasian ethnicity 3805 (97.1) 
Height, cm 169.5 (9.4) 
Weight, kg 75.1 (15.1) 
BMI, kg/m2 26.6 (4.3) 
Average household income  
< £18,000 480 (13.6) 
£18,000 to £30,999 1036 (29.3) 
£31,000 to £51,999 1054 (29.9) 
£52,000 to £100,000 750 (21.2) 
> £100,000 210 (5.9) 
Townsend deprivation index -2.00 (2.65) 
Degree-level or professional education 2495 (63.6) 
Employment status  
Skilled job 3097 (79.1) 
Unskilled job 693 (17.7) 
Unemployed 121 (3.1) 
Retired 4 (0.1) 
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Clinical characteristics  
Systolic blood pressure, mmHg 137 (18) 
Diastolic blood pressure, mmHg 79 (10) 
Heart rate, bpm 71 (12) 
Hypertension 1108 (28.3) 
Dyslipidaemia 866 (22.1) 
Diabetes mellitus 175 (4.5) 
Antihypertensive medication 786 (20.1) 
Lipid-lowering medication  718 (18.3) 
Insulin  25 (0.6) 
Smoking status  
Never 2398 (61.3) 
Previous 1342 (34.3) 
Current 171 (4.4) 
Regular alcohol use (≥ 3 times per week) 1757 (44.8) 
Seven-day average acceleration, milli-gravity 28.19 (9.17) 
  
Cardiac phenotypes  
LV EDV, ml 142.3 (33.0) 
LV ESV, ml 58.1 (18.3) 
LV SV, ml 84.2 (19.3) 
LV EF, % 59.5 (6.2) 
LV mass, g 88.4 (24.0) 
LV remodelling patterns  
 33 
Normal 3504 (92.2) 
Concentric remodelling 140 (3.7) 
Eccentric hypertrophy 123 (3.2) 
Concentric hypertrophy 33 (0.9) 
RV EDV, ml 151.2 (37.1) 
RV ESV, ml 66.7 (22.3) 
RV SV, ml 84.5 (19.4) 
RV EF, % 56.5 (6.5) 
LA maximal volume, ml 66.7 (20.2) 
LA minimal volume, ml 27.6 (12.1) 
LA SV, ml 39.1 (11.2) 
LA EF, % 59.5 (8.3) 
RA maximal volume, ml 78.4 (25.4) 
RA minimal volume, ml 45.2 (18.1) 
RA SV, ml 33.2 (12.5) 
RA EF, % 42.7 (10.3) 
  
Ambient pollutants  
PM2.5*, µg/m3 9.9 (1.32) 
PM10*, µg/m3 18.8 (2.11) 
PMcoarse*, µg/m3 6.1 (0.72) 
PM2.5 absorbance (elemental carbon)*, per meter 1.13 (0.29) 
NO2*, µg/m3 28.2 (11.4) 
NOx*, µg/m3 41.5 (17.1) 
24-hour sound level averaged over 1 year*, dB 54.9 (3.6) 
 34 
Distance to the nearest major road*, m 356 (555) 
Traffic intensity on the nearest major road per day 
averaged over 1 year*, vehicles/day 
15896 (10947) 
Duration between exposure estimate and imaging visit*, 
years 
5.2 (0.6) 
Numbers are mean (SD) or number (%), unless otherwise stated.  
BMI, body mass index; LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right 
atrium; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; EF, 
ejection fraction; MVR, mass to end-diastolic volume ratio. 
*Indicates data presented as median (interquartile range) 
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Table 2. Associations between annual average particulate matter concentration and cardiac phenotypes  
 
Phenotype 
PM2.5 (per IQR [1.32 µg/m3] 
change) 
PM10 (per IQR [2.11 µg/m3] 
change) 
PMcoarse (per IQR [0.72 
µg/m3] change) 
PM2.5 absorbance (per IQR 

















LV EDV* 0.82 [0.09 - 1.55] 0.027 0.81 [0.12 - 1.5] 0.021 0.37 [-0.03 - 0.76] 0.069 0.34 [-0.26 - 0.94] 0.272 
LV ESV* 1.28 [0.15 - 2.43] 0.027 1.07 [0 - 2.15] 0.049 0.47 [-0.14 - 1.09] 0.133 0.28 [-0.64 - 1.21] 0.557 
LV EF -0.16 [-0.45 - 0.13] 0.269 -0.09 [-0.36 - 0.18] 0.507 -0.05 [-0.2 - 0.1] 0.527 0.01 [-0.22 - 0.24] 0.948 
LV mass* 0.4 [-0.39 - 1.2] 0.321 0.4 [-0.35 - 1.16] 0.292 0.22 [-0.21 - 0.66] 0.316 0.06 [-0.59 - 0.71] 0.865 
RV EDV* 0.85 [0.12 - 1.58] 0.023 0.77 [0.08 - 1.46] 0.028 0.27 [-0.12 - 0.67] 0.176 0.36 [-0.24 - 0.96] 0.245 
RV ESV* 1.11 [-0.01 - 2.25] 0.051 0.66 [-0.39 - 1.73] 0.218 0.39 [-0.22 - 1] 0.209 0.42 [-0.49 - 1.35] 0.364 
RV EF -0.08 [-0.36 - 0.21] 0.598 0.07 [-0.19 - 0.34] 0.6 -0.05 [-0.2 - 0.1] 0.503 -0.03 [-0.26 - 0.2] 0.783 
LA maximal 
volume* 0.55 [-0.75 - 1.86] 0.409 0.46 [-0.74 - 1.68] 0.457 0.23 [-0.46 - 0.92] 0.516 0.7 [-0.35 - 1.76] 0.191 
LA EF -0.06 [-0.47 - 0.35] 0.778 -0.13 [-0.5 - 0.25] 0.504 -0.04 [-0.26 - 0.17] 0.686 -0.07 [-0.4 - 0.26] 0.672 
RA maximal 
volume* -0.23 [-1.5 - 1.05] 0.719 -0.85 [-2.01 - 0.33] 0.159 -0.55 [-1.22 - 0.13] 0.114 -0.61 [-1.63 - 0.41] 0.24 
RA EF -0.1 [-0.57 - 0.37] 0.678 -0.1 [-0.55 - 0.34] 0.65 -0.01 [-0.27 - 0.24] 0.911 0.23 [-0.16 - 0.62] 0.247 
LV geometric 
patterns         
Concentric 
remodelling† 1.03 [0.15 - 7.25] 0.976 1.04 [0.15 - 7.33] 0.97 1.01 [0.14 - 7.11] 0.995 1.06 [0.15 - 7.45] 0.957 
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Eccentric 
hypertrophy† 1.11 [0.67 - 1.85] 0.682 0.98 [0.61 - 1.58] 0.938 0.84 [0.6 - 1.18] 0.314 0.95 [0.62 - 1.45] 0.811 
Concentric 
hypertrophy† 1.02 [0.41 - 2.51] 0.974 1.11 [0.45 - 2.73] 0.826 1.13 [0.46 - 2.79] 0.785 1.05 [0.43 - 2.59] 0.914 
All estimates were fully-adjusted for age, sex, ethnicity, height, body mass index, socioeconomic factors, cardiac risk factors, medications and 
physical activity.  
*log-transformed dependent variables – their effect estimates represent percentage change per IQR increase in exposure variable. 
†The effect estimates for these variables represent the odds ratio, where reference is normal LV geometry.  
IQR, interquartile range; CI, confidence interval; LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right atrium; EDV, end-diastolic 










Table 3. Associations between annual average nitrogen dioxide and nitrogen oxides concentration and 
cardiac phenotypes  
 
Phenotype 
NO2 (per IQR [11.4 µg/m3] 
change) 
NOx (per SD [17.1 µg/m3] 
change) 
Effect size 
[95% CI] P-value 
Effect size 
[95% CI] P-value 
LV EDV* 0.91 [0.12 - 1.7] 0.025 0.63 [-0.05 - 1.33] 0.071 
LV ESV* 0.88 [-0.35 - 2.12] 0.161 1 [-0.07 - 2.09] 0.066 
LV EF 0.01 [-0.3 - 0.32] 0.965 -0.13 [-0.4 - 0.14] 0.334 
LV mass* -0.35 [-1.2 - 0.51] 0.424 0.13 [-0.62 - 0.89] 0.73 
RV EDV* 0.85 [0.06 - 1.65] 0.035 0.58 [-0.11 - 1.26] 0.099 
RV ESV* 0.64 [-0.58 - 1.87] 0.306 0.83 [-0.22 - 1.89] 0.123 
RV EF 0.13 [-0.18 - 0.43] 0.421 -0.08 [-0.35 - 0.18] 0.535 
LA maximal volume* 0.74 [-0.65 - 2.15] 0.299 0.48 [-0.74 - 1.71] 0.442 
LA EF -0.33 [-0.78 - 0.11] 0.145 -0.2 [-0.59 - 0.19] 0.309 
RA maximal volume* -0.66 [-2.02 - 0.72] 0.347 -0.42 [-1.61 - 0.77] 0.486 
RA EF -0.14 [-0.65 - 0.37] 0.594 -0.14 [-0.59 - 0.3] 0.532 
LV geometric patterns     
Concentric remodelling† 0.93 [0.13 - 6.61] 0.946 0.93 [0.13 - 6.6] 0.945 
Eccentric hypertrophy† 1.05 [0.61 - 1.8] 0.855 1.03 [0.65 - 1.64] 0.891 
Concentric hypertrophy† 0.86 [0.35 - 2.11] 0.735 0.93 [0.38 - 2.3] 0.876 
All estimates were fully-adjusted for age, sex, ethnicity, height, body mass index, socioeconomic factors, cardiac 
risk factors, medications and physical activity.  
*log-transformed dependent variables – their effect estimates represent percentage change per IQR increase in 
exposure variable. 
†The effect estimates for these variables represent the odds ratio, where reference is normal LV geometry.  
IQR, interquartile range; CI, confidence interval; LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right 








Table 4. Associations between annual average 24-hour sound level, distance to nearest major road and annual average 
traffic intensity on the nearest major road over 24 hour and cardiac phenotypes 
 
Phenotype 
Average 24-hour sound level 
(per IQR [3.6 dB] change) 
Distance to the nearest major 
road (per IQR [555 m] 
change) 
Average traffic intensity (per 














LV EDV* 0.36 [-0.07 - 0.78] 0.1 -0.45 [-0.95 - 0.06] 0.082 0.16 [-0.08 - 0.41] 0.195 
LV ESV* 0.69 [0.03 - 1.35] 0.041 -0.99 [-1.77 - -0.2] 0.014 0.02 [-0.36 - 0.41] 0.906 
LV EF -0.12 [-0.29 - 0.04] 0.141 0.2 [0 - 0.4] 0.05 0.05 [-0.05 - 0.15] 0.302 
LV mass* 0.36 [-0.1 - 0.82] 0.126 -0.74 [-1.3 - -0.18] 0.01 0.11 [-0.16 - 0.38] 0.415 
RV EDV* 0.05 [-0.37 - 0.48] 0.808 -0.65 [-1.16 - -0.15] 0.011 0.17 [-0.08 - 0.42] 0.19 
RV ESV* 0.28 [-0.37 - 0.94] 0.402 -1.02 [-1.8 - -0.25] 0.01 0.12 [-0.26 - 0.5] 0.541 
RV EF -0.09 [-0.26 - 0.07] 0.259 0.15 [-0.05 - 0.35] 0.134 0.02 [-0.08 - 0.11] 0.705 
LA maximal 
volume* 0.21 [-0.55 - 0.98] 0.583 -0.32 [-1.22 - 0.58] 0.48 0.01 [-0.42 - 0.45] 0.954 
LA EF -0.06 [-0.31 - 0.18] 0.602 0.11 [-0.18 - 0.4] 0.46 -0.01 [-0.15 - 0.13] 0.865 
RA maximal 
volume* -0.12 [-0.85 - 0.63] 0.759 -0.36 [-1.24 - 0.53] 0.429 -0.29 [-0.72 - 0.14] 0.189 
RA EF -0.05 [-0.32 - 0.23] 0.749 -0.05 [-0.39 - 0.28] 0.751 0.05 [-0.11 - 0.21] 0.548 
LV geometric 
patterns       
Concentric 
remodelling† 1.02 [0.14 - 7.17] 0.986 0.99 [0.14 - 6.99] 0.992 1.01 [0.14 - 7.13] 0.992 
Eccentric 
hypertrophy† 0.93 [0.68 - 1.27] 0.659 0.91 [0.62 - 1.35] 0.654 0.83 [0.61 - 1.12] 0.216 
Concentric 
hypertrophy† 1.01 [0.41 - 2.49] 0.985 1.06 [0.43 - 2.61] 0.904 1.1 [0.44 - 2.71] 0.841 
All estimates were fully-adjusted for age, sex, ethnicity, height, body mass index, socioeconomic factors, cardiac 
risk factors, medications and physical activity.  
*log-transformed dependent variables – their effect estimates represent percentage change per IQR increase in 
exposure variable. 
†The effect estimates for these variables represent the odds ratio, where reference is normal LV geometry.  
IQR, interquartile range; CI, confidence interval; LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right 










Participants with CMR 
studies
(N=5,065)
Change of address 
between baseline and 
imaging visits
(N=738)
Participants with a fixed 
home address between 






Participants included in 
the final analysis
(N=3,920)
